Federal Judges v. Science

Katie Wells was born in 1981 with serious birth defects. Her parents attributed them to a contraceptive jelly and sued the maker, Ortho Pharmaceutical Judge Marvin Shoob of the U.S. District Court in Georgia ruled they had proved their case and assessed $5 million in damages against Ortho. The Court of Appeals declined to overturn the judgment and last month the Supreme Court refused to intervene. What is wrong with that? First, the facts. Scientific experts often differ and the courts generally

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

First, the facts. Scientific experts often differ and the courts generally decide, with some skill, which to believe. But with spermicides like Ortho's there is no serious difference among experts. After reviewing some 20 epidemiological studies, an expert committee advised the Food and Drug Administration in 1983 that the preponderance of available evidence "indicates no association" between spermicides and birth defects.

How then could Judge Shoob have ruled otherwise? Despite the written evidence of the scientific literature, he focused on the real testimony given in his court, and says he "paid close attention to each expert's demeanor and tone." Ortho's witnesses included prominent epidemiologists but were gravely deficient in the demeanor department.

One had impressive credentials, Judge Shoob conceded yet "lacked credibility." Of another, the judge said "his overall demeanor and manner indicated a degree of bias." He cited objective grounds for doubting one main witness, who had not disclosed ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies